Blog / Subscriber Request Series: Celgene Corp (NAS:CELG) and Bristol Myers (NYS:BMY)

Subscriber Request Series: Celgene Corp (NAS:CELG) and Bristol Myers (NYS:BMY)

FAST Graphs Analyze Out Loud

Celgene Corp $CELG:

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Bristol Myers Squibb Co $BMY:

Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.